GSK to relocate UK R&D centre from Stevenage to Cambridge

CE2026-07-29T11:17:00

Source:

Investment provides significant growth opportunity for UK’s life sciences sector and in shaping the country’s research and manufacturing footprint.

After five decades at its Stevenage site in the UK, GSK is moving to pastures new under plans to accelerate its R&D operations.

The pharmaceutical giant is building a new 300,000ft² research facility on the Cambridge Biomedical Campus in…

Already a member? Sign-in

Unlock

Driving innovation in pharma manufacturing

European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.

Become a member to continue reading

By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:

Unlimited access to industry intelligence that can make a difference to your business
A weekly newsletter keeping the most vital information at the front of your thinking
Exclusive invitations to powerful webinars and events featuring high profile experts
Access to deep-dive reports and analysis that reveal exciting new opportunities for business growth and transformation

Become a member